NCIt definition : A phosphoinositide 3-kinase (PI3K) inhibitor with potential antineoplastic activity.
Copanlisib inhibits the activation of the PI3K signaling pathway, which may result
in inhibition of tumor cell growth and survival in susceptible tumor cell populations.
Activation of the PI3K signaling pathway is frequently associated with tumorigenesis
and dysregulated PI3K signaling may contribute to tumor resistance to a variety of
antineoplastic agents.;
UNII : WI6V529FZ9;
InChIKey : PZBCKZWLPGJMAO-UHFFFAOYSA-N;
CAS number : 1032568-63-0; a href https://gsrs.ncats.nih.gov/ginas/app/beta/browse-substance?search 1032568-63-0
alt lien vers site G-SRS target _blank img src /img/logos/logo_g-srs.png alt Logo
G-SRS /a ;